Chuck Harrell is an Associate Professor in the Department of Pathology at Virginia Commonwealth University, whose research interests include cancer genomics, proteomics, metastasis, patient-derived breast cancer xenograft models, drug resistance, and targeted therapeutics. He also serves as a member of the American Association for Cancer Research and the Metastasis Research Society. He received his Bachelor of Science in Biological Sciences from North Carolina State University and earned his Ph.D. in Cell and Developmental Biology from the University of Colorado. Post-doctoral training at the University of North Carolina at Chapel Hill focused on bioinformatic analyses of breast cancer. He is an active member of the PDX Network organization and is a Principal Investigator for a VCU-led team effort to generate new patient-derived xenografts, with an emphasis on developing new model systems that effectively represent our patient population.